FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976755168> ?p ?o ?g. }

• W1976755168 endingPage "1580" @default.
• W1976755168 startingPage "1572" @default.
• W1976755168 abstract "<h3>Objective:</h3> To determine the neurocognitive deficits associated with newly diagnosed untreated childhood absence epilepsy (CAE), develop a model describing the factorial structure of items measuring academic achievement and 3 neuropsychological constructs, and determine short-term differential neuropsychological effects on attention among ethosuximide, valproic acid, and lamotrigine. <h3>Methods:</h3> Subjects with newly diagnosed CAE entering a double-blind, randomized controlled clinical trial had neuropsychological testing including assessments of general intellectual functioning, attention, memory, executive function, and achievement. Attention was reassessed at the week 16–20 visit. <h3>Results:</h3> At study entry, 36% of the cohort exhibited attention deficits despite otherwise intact neurocognitive functioning. Structural equation modeling of baseline neuropsychological data revealed a direct sequential effect among attention, memory, executive function, and academic achievement. At the week 16–20 visit, attention deficits persisted even if seizure freedom was attained. More subjects receiving valproic acid (49%) had attention deficits than subjects receiving ethosuximide (32%) or lamotrigine (24%) (<i>p</i> = 0.0006). Parental assessment did not reliably detect attention deficits before or after treatment (<i>p</i> < 0.0001). <h3>Conclusions:</h3> Children with CAE have a high rate of pretreatment attentional deficits that persist despite seizure freedom. Rates are disproportionately higher for valproic acid treatment compared with ethosuximide or lamotrigine. Parents do not recognize these attentional deficits. These deficits present a threat to academic achievement. Vigilant cognitive and behavioral assessment of these children is warranted. <h3>Classification of evidence:</h3> This study provides Class I evidence that valproic acid is associated with more significant attentional dysfunction than ethosuximide or lamotrigine in children with newly diagnosed CAE." @default.
• W1976755168 created "2016-06-24" @default.
• W1976755168 creator A5002880520 @default.
• W1976755168 creator A5007123680 @default.
• W1976755168 creator A5010106007 @default.
• W1976755168 creator A5015157558 @default.
• W1976755168 creator A5042209669 @default.
• W1976755168 creator A5050480465 @default.
• W1976755168 creator A5068288914 @default.
• W1976755168 creator A5071831642 @default.
• W1976755168 creator A5071956286 @default.
• W1976755168 date "2013-10-02" @default.
• W1976755168 modified "2023-10-08" @default.
• W1976755168 title "Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy" @default.
• W1976755168 cites W1515239432 @default.
• W1976755168 cites W1531719530 @default.
• W1976755168 cites W1555923997 @default.
• W1976755168 cites W1592895288 @default.
• W1976755168 cites W1606762078 @default.
• W1976755168 cites W183104282 @default.
• W1976755168 cites W1909219519 @default.
• W1976755168 cites W1951203427 @default.
• W1976755168 cites W1958019198 @default.
• W1976755168 cites W1965994018 @default.
• W1976755168 cites W1966601175 @default.
• W1976755168 cites W1973880443 @default.
• W1976755168 cites W1974622188 @default.
• W1976755168 cites W1976876975 @default.
• W1976755168 cites W1978845935 @default.
• W1976755168 cites W1982153675 @default.
• W1976755168 cites W1983352091 @default.
• W1976755168 cites W1983825283 @default.
• W1976755168 cites W1995863987 @default.
• W1976755168 cites W1998379785 @default.
• W1976755168 cites W2002052311 @default.
• W1976755168 cites W2012924701 @default.
• W1976755168 cites W2014731565 @default.
• W1976755168 cites W2030113059 @default.
• W1976755168 cites W2042291251 @default.
• W1976755168 cites W2052485596 @default.
• W1976755168 cites W2052806196 @default.
• W1976755168 cites W2058854393 @default.
• W1976755168 cites W2065698894 @default.
• W1976755168 cites W2072064155 @default.
• W1976755168 cites W2082880546 @default.
• W1976755168 cites W2115221395 @default.
• W1976755168 cites W2145098179 @default.
• W1976755168 cites W2167518632 @default.
• W1976755168 cites W2171074660 @default.
• W1976755168 cites W2770777866 @default.
• W1976755168 cites W2808339913 @default.
• W1976755168 cites W1595622831 @default.
• W1976755168 doi "https://doi.org/10.1212/wnl.0b013e3182a9f3ca" @default.
• W1976755168 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3806916" @default.
• W1976755168 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24089388" @default.
• W1976755168 hasPublicationYear "2013" @default.
• W1976755168 type Work @default.
• W1976755168 sameAs 1976755168 @default.
• W1976755168 citedByCount "161" @default.
• W1976755168 countsByYear W19767551682013 @default.
• W1976755168 countsByYear W19767551682014 @default.
• W1976755168 countsByYear W19767551682015 @default.
• W1976755168 countsByYear W19767551682016 @default.
• W1976755168 countsByYear W19767551682017 @default.
• W1976755168 countsByYear W19767551682018 @default.
• W1976755168 countsByYear W19767551682019 @default.
• W1976755168 countsByYear W19767551682020 @default.
• W1976755168 countsByYear W19767551682021 @default.
• W1976755168 countsByYear W19767551682022 @default.
• W1976755168 countsByYear W19767551682023 @default.
• W1976755168 crossrefType "journal-article" @default.
• W1976755168 hasAuthorship W1976755168A5002880520 @default.
• W1976755168 hasAuthorship W1976755168A5007123680 @default.
• W1976755168 hasAuthorship W1976755168A5010106007 @default.
• W1976755168 hasAuthorship W1976755168A5015157558 @default.
• W1976755168 hasAuthorship W1976755168A5042209669 @default.
• W1976755168 hasAuthorship W1976755168A5050480465 @default.
• W1976755168 hasAuthorship W1976755168A5068288914 @default.
• W1976755168 hasAuthorship W1976755168A5071831642 @default.
• W1976755168 hasAuthorship W1976755168A5071956286 @default.
• W1976755168 hasBestOaLocation W19767551682 @default.
• W1976755168 hasConcept C118552586 @default.
• W1976755168 hasConcept C14216870 @default.
• W1976755168 hasConcept C15744967 @default.
• W1976755168 hasConcept C169900460 @default.
• W1976755168 hasConcept C172467417 @default.
• W1976755168 hasConcept C187212893 @default.
• W1976755168 hasConcept C2777172819 @default.
• W1976755168 hasConcept C2778186239 @default.
• W1976755168 hasConcept C2778566530 @default.
• W1976755168 hasConcept C2778802184 @default.
• W1976755168 hasConcept C536788834 @default.
• W1976755168 hasConcept C548259974 @default.
• W1976755168 hasConcept C70410870 @default.
• W1976755168 hasConcept C71924100 @default.
• W1976755168 hasConceptScore W1976755168C118552586 @default.
• W1976755168 hasConceptScore W1976755168C14216870 @default.
• W1976755168 hasConceptScore W1976755168C15744967 @default.

• next